
Katy Meyer Ebner
Examiner (ID: 7511, Phone: (571)272-5830 , Office: P/3618 )
| Most Active Art Unit | 3618 |
| Art Unit(s) | 3613, 3618 |
| Total Applications | 931 |
| Issued Applications | 606 |
| Pending Applications | 62 |
| Abandoned Applications | 280 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 19860860
[patent_doc_number] => 20250099646
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-03-27
[patent_title] => WOUND HEALING DRESSINGS AND FORMULATIONS AND METHODS OF USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/977672
[patent_app_country] => US
[patent_app_date] => 2024-12-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 63409
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 187
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18977672
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/977672 | WOUND HEALING DRESSINGS AND FORMULATIONS AND METHODS OF USE THEREOF | Dec 10, 2024 | Pending |
Array
(
[id] => 19784095
[patent_doc_number] => 20250057774
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-02-20
[patent_title] => FAST DISSOLVING SOFTGEL CAPSULES
[patent_app_type] => utility
[patent_app_number] => 18/940147
[patent_app_country] => US
[patent_app_date] => 2024-11-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9171
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18940147
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/940147 | FAST DISSOLVING SOFTGEL CAPSULES | Nov 6, 2024 | Pending |
Array
(
[id] => 19784095
[patent_doc_number] => 20250057774
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-02-20
[patent_title] => FAST DISSOLVING SOFTGEL CAPSULES
[patent_app_type] => utility
[patent_app_number] => 18/940147
[patent_app_country] => US
[patent_app_date] => 2024-11-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9171
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18940147
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/940147 | FAST DISSOLVING SOFTGEL CAPSULES | Nov 6, 2024 | Pending |
Array
(
[id] => 19541855
[patent_doc_number] => 20240358891
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-10-31
[patent_title] => DEVICES AND METHODS FOR NERVE REGENERATION
[patent_app_type] => utility
[patent_app_number] => 18/771006
[patent_app_country] => US
[patent_app_date] => 2024-07-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6622
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 339
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18771006
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/771006 | DEVICES AND METHODS FOR NERVE REGENERATION | Jul 11, 2024 | Pending |
Array
(
[id] => 19541713
[patent_doc_number] => 20240358749
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-10-31
[patent_title] => COMPOSITIONS FOR THE TREATMENT OF INFECTIONS IN FEET
[patent_app_type] => utility
[patent_app_number] => 18/765884
[patent_app_country] => US
[patent_app_date] => 2024-07-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4322
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18765884
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/765884 | COMPOSITIONS FOR THE TREATMENT OF INFECTIONS IN FEET | Jul 7, 2024 | Pending |
Array
(
[id] => 19743945
[patent_doc_number] => 20250032510
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-01-30
[patent_title] => AMORPHOUS SOLID DISPERSION GANAXOLONE FORMULATION
[patent_app_type] => utility
[patent_app_number] => 18/731812
[patent_app_country] => US
[patent_app_date] => 2024-06-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18789
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18731812
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/731812 | AMORPHOUS SOLID DISPERSION GANAXOLONE FORMULATION | Jun 2, 2024 | Pending |
Array
(
[id] => 19446506
[patent_doc_number] => 20240306636
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-09-19
[patent_title] => CELLULOSE NANOCRYSTAL-BASED EMULSIONS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/673405
[patent_app_country] => US
[patent_app_date] => 2024-05-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5451
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18673405
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/673405 | CELLULOSE NANOCRYSTAL-BASED EMULSIONS AND USES THEREOF | May 23, 2024 | Pending |
Array
(
[id] => 19570451
[patent_doc_number] => 20240374743
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-11-14
[patent_title] => BLETILLA STRIATA POLYSACCHARIDE IRON COMPLEX, PREPARATION METHOD THEREFOR AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/660885
[patent_app_country] => US
[patent_app_date] => 2024-05-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9017
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 115
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18660885
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/660885 | BLETILLA STRIATA POLYSACCHARIDE IRON COMPLEX, PREPARATION METHOD THEREFOR AND USE THEREOF | May 9, 2024 | Abandoned |
Array
(
[id] => 19846727
[patent_doc_number] => 20250092078
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-03-20
[patent_title] => COMPOUNDS FOR ACTIVATING INVARIANT NATURAL KILLER T-CELLS AND METHODS OF USE IN ELIMINATING INFLAMMATORY SENESCENT CELLS
[patent_app_type] => utility
[patent_app_number] => 18/653604
[patent_app_country] => US
[patent_app_date] => 2024-05-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 43260
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18653604
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/653604 | COMPOUNDS FOR ACTIVATING INVARIANT NATURAL KILLER T-CELLS AND METHODS OF USE IN ELIMINATING INFLAMMATORY SENESCENT CELLS | May 1, 2024 | Pending |
Array
(
[id] => 19846727
[patent_doc_number] => 20250092078
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-03-20
[patent_title] => COMPOUNDS FOR ACTIVATING INVARIANT NATURAL KILLER T-CELLS AND METHODS OF USE IN ELIMINATING INFLAMMATORY SENESCENT CELLS
[patent_app_type] => utility
[patent_app_number] => 18/653604
[patent_app_country] => US
[patent_app_date] => 2024-05-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 43260
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18653604
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/653604 | COMPOUNDS FOR ACTIVATING INVARIANT NATURAL KILLER T-CELLS AND METHODS OF USE IN ELIMINATING INFLAMMATORY SENESCENT CELLS | May 1, 2024 | Pending |
Array
(
[id] => 19296430
[patent_doc_number] => 20240224993
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-07-11
[patent_title] => ANTIMICROBIAL COMPOSITIONS
[patent_app_type] => utility
[patent_app_number] => 18/613465
[patent_app_country] => US
[patent_app_date] => 2024-03-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11409
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18613465
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/613465 | ANTIMICROBIAL COMPOSITIONS | Mar 21, 2024 | Pending |
Array
(
[id] => 19297528
[patent_doc_number] => 20240226093
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-07-11
[patent_title] => DRUG PRODUCTS FOR INTRANASAL ADMINISTRATION AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/602972
[patent_app_country] => US
[patent_app_date] => 2024-03-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21318
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 78
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18602972
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/602972 | DRUG PRODUCTS FOR INTRANASAL ADMINISTRATION AND USES THEREOF | Mar 11, 2024 | Pending |
Array
(
[id] => 19279888
[patent_doc_number] => 20240216360
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-07-04
[patent_title] => DRUG PRODUCTS FOR INTRANASAL ADMINISTRATION AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/602984
[patent_app_country] => US
[patent_app_date] => 2024-03-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21305
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 80
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18602984
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/602984 | DRUG PRODUCTS FOR INTRANASAL ADMINISTRATION AND USES THEREOF | Mar 11, 2024 | Pending |
Array
(
[id] => 19769957
[patent_doc_number] => 20250051383
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-02-13
[patent_title] => NOVEL FEAZD, NIAZD, AND CUAZD COMPLEXES INCORPORATING 1-(2-HYDROXYPHENYLAZO)-2-NAPHTHOL (H2AZD) FOR BIOLOGICAL APPLICATIONS
[patent_app_type] => utility
[patent_app_number] => 18/417989
[patent_app_country] => US
[patent_app_date] => 2024-01-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5935
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18417989
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/417989 | NOVEL FEAZD, NIAZD, AND CUAZD COMPLEXES INCORPORATING 1-(2-HYDROXYPHENYLAZO)-2-NAPHTHOL (H2AZD) FOR BIOLOGICAL APPLICATIONS | Jan 18, 2024 | Abandoned |
Array
(
[id] => 19717323
[patent_doc_number] => 12202846
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2025-01-21
[patent_title] => FeAZD, NiAZD, and CuAZD complexes incorporating 1-(2-hydroxyphenylazo)-2-naphthol (H
[patent_app_type] => utility
[patent_app_number] => 18/417945
[patent_app_country] => US
[patent_app_date] => 2024-01-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 6
[patent_no_of_words] => 5985
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18417945
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/417945 | FeAZD, NiAZD, and CuAZD complexes incorporating 1-(2-hydroxyphenylazo)-2-naphthol (H | Jan 18, 2024 | Issued |
Array
(
[id] => 19125677
[patent_doc_number] => 20240131030
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-04-25
[patent_title] => METHODS OF TREATING B-CELL PROLIFERATIVE DISORDER
[patent_app_type] => utility
[patent_app_number] => 18/541928
[patent_app_country] => US
[patent_app_date] => 2023-12-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 51346
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 66
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18541928
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/541928 | METHODS OF TREATING B-CELL PROLIFERATIVE DISORDER | Dec 14, 2023 | Pending |
Array
(
[id] => 20212509
[patent_doc_number] => 12409143
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-09-09
[patent_title] => Softgel capsules and a method for preparing the softgel capsules
[patent_app_type] => utility
[patent_app_number] => 18/842531
[patent_app_country] => US
[patent_app_date] => 2023-12-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 6612
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18842531
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/842531 | Softgel capsules and a method for preparing the softgel capsules | Dec 12, 2023 | Issued |
Array
(
[id] => 19125665
[patent_doc_number] => 20240131018
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-04-25
[patent_title] => PHARMACEUTICAL COMPOSITIONS OF CABOZANTINIB
[patent_app_type] => utility
[patent_app_number] => 18/523274
[patent_app_country] => US
[patent_app_date] => 2023-11-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18948
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 72
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18523274
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/523274 | PHARMACEUTICAL COMPOSITIONS OF CABOZANTINIB | Nov 28, 2023 | Abandoned |
Array
(
[id] => 19032316
[patent_doc_number] => 20240082131
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-03-14
[patent_title] => COMPOSITION FOR IMPROVING SKIN CONDITIONS
[patent_app_type] => utility
[patent_app_number] => 18/513133
[patent_app_country] => US
[patent_app_date] => 2023-11-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4891
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18513133
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/513133 | COMPOSITION FOR IMPROVING SKIN CONDITIONS | Nov 16, 2023 | Pending |
Array
(
[id] => 19135575
[patent_doc_number] => 11970505
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2024-04-30
[patent_title] => Pyridino-2,16-dioxapentacyclo[7.7.5.0
[patent_app_type] => utility
[patent_app_number] => 18/387552
[patent_app_country] => US
[patent_app_date] => 2023-11-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3968
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 8
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18387552
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/387552 | Pyridino-2,16-dioxapentacyclo[7.7.5.0 | Nov 6, 2023 | Issued |